MK, the obvious reason for the action is traders are focusing on the short term downer of Abbott not launching by the end of June. As we all know, an approval in Europe is several fold more significant. Further, we learned in the conf call that the Europe specifications will allow for a longer shelf life.
As to exactly what the Health Canada specifications are, only Apricus, Abbott and Health Canada know.
News 
Market Data 
Discover 
